Cosmic microwave background anisotropy power spectrum statistics for high precision cosmology

As the era of high precision cosmology approaches, the empirically determined power spectrum of the microwave background anisotropy, $C_l$, will provide a crucial test for cosmological theories. We present a unified semi-analytic framework for the study of the statistical properties of the $C_l$ coefficients computed from the results of balloon, ground based, and satellite experiments. An illustrative application shows that commonly used approximations {\it bias} the estimation of the baryon parameter $\Omega_b$ at the 1% level even for a satellite capturing as much as $\sim 70$% of the sky.Comment: 4 pages, 3 figures. Also available at http://www.tac.dk/~wandelt/downloads.htm

On the APM power spectrum and the CMB anisotropy: Evidence for a phase transition during inflation?

Adams et al. (1997b) have noted that according to our current understanding of the unification of fundamental interactions, there should have been phase transitions associated with spontaneous symmetry breaking {\em during} the inflationary era. This may have resulted in the breaking of scale-invariance of the primordial density perturbation for brief periods. A possible such feature was identified in the power spectrum of galaxy clustering in the APM survey at the scale $k \sim 0.1 h$ Mpc^{-1} and it was shown that the secondary acoustic peaks in the power spectrum of the CMB anisotropy should consequently be suppressed. We demonstrate that this prediction is confirmed by the recent Boomerang and Maxima observations, which favour a step-like spectral feature in the range $k \sim (0.06-0.6)h$ Mpc^{-1}, independently of the similar previous indication from the APM data. Such a spectral break enables an excellent fit to both APM and CMB data with a baryon density consistent with the BBN value. It also allows the possibility of a matter-dominated universe with zero cosmological constant, which we show can now account for even the evolution of the abundance of rich clusters.Comment: 11 pages (LaTeX, mn.sty) incl. 9 eps figs; small changes to match version accepted for publication in MNRA

Search for Monopoles Above the 15-Foot Bubble Chamber

Magnetic monopoles having energies less than about 40 TeV will be slowed to their terminal velocity by the earth's atmosphere. They may then be gathered by the fringing magnetic field of the 15-foot bubble chamber. We propose placing detectors of Lexan and nuclear emulsion at convenient locations above and below the bubble chamber. Such a systom would be sensitive to monopole masses between 10 GeV and 100 TeV and to monopole charges between {approx}0.7 and 10 hc/2e. The experiment would require the construction of a special light roof and would run for 5 weeks during a time when the bubble chamber is filled with air and not in use for other experiments. This study would lower the existing limit on in-flight detection of monopoles (at the earth's surface) by a factor of 20

An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics

For a decade, The Cancer Genome Atlas (TCGA) program collected clinicopathologic annotation data along with multi-platform molecular profiles of more than 11,000 human tumors across 33 different cancer types. TCGA clinical data contain key features representing the democratized nature of the data collection process. To ensure proper use of this large clinical dataset associated with genomic features, we developed a standardized dataset named the TCGA Pan-Cancer Clinical Data Resource (TCGA-CDR), which includes four major clinical outcome endpoints. In addition to detailing major challenges and statistical limitations encountered during the effort of integrating the acquired clinical data, we present a summary that includes endpoint usage recommendations for each cancer type. These TCGA-CDR findings appear to be consistent with cancer genomics studies independent of the TCGA effort and provide opportunities for investigating cancer biology using clinical correlates at an unprecedented scale. Analysis of clinicopathologic annotations for over 11,000 cancer patients in the TCGA program leads to the generation of TCGA Clinical Data Resource, which provides recommendations of clinical outcome endpoint usage for 33 cancer types

Cotton in the new millennium: advances, economics, perceptions and problems

Cotton is the most significant natural fibre and has been a preferred choice of the textile industry and consumers since the industrial revolution began. The share of man-made fibres, both regenerated and synthetic fibres, has grown considerably in recent times but cotton production has also been on the rise and accounts for about half of the fibres used for apparel and textile goods. To cotton’s advantage, the premium attached to the presence of cotton fibre and the general positive consumer perception is well established, however, compared to commodity man-made fibres and high performance fibres, cotton has limitations in terms of its mechanical properties but can help to overcome moisture management issues that arise with performance apparel during active wear. This issue of Textile Progress aims to: i. Report on advances in cotton cultivation and processing as well as improvements to conventional cotton cultivation and ginning. The processing of cotton in the textile industry from fibre to finished fabric, cotton and its blends, and their applications in technical textiles are also covered. ii. Explore the economic impact of cotton in different parts of the world including an overview of global cotton trade. iii. Examine the environmental perception of cotton fibre and efforts in organic and genetically-modified (GM) cotton production. The topic of naturally-coloured cotton, post-consumer waste is covered and the environmental impacts of cotton cultivation and processing are discussed. Hazardous effects of cultivation, such as the extensive use of pesticides, insecticides and irrigation with fresh water, and consequences of the use of GM cotton and cotton fibres in general on the climate are summarised and the effects of cotton processing on workers are addressed. The potential hazards during cotton cultivation, processing and use are also included. iv. Examine how the properties of cotton textiles can be enhanced, for example, by improving wrinkle recovery and reducing the flammability of cotton fibre

Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials

Stromal tumor-infiltrating lymphocytes (sTILs) are a potential predictive biomarker for immunotherapy response in metastatic triple-negative breast cancer (TNBC). To incorporate sTILs into clinical trials and diagnostics, reliable assessment is essential. In this review, we propose a new concept, namely the implementation of a risk-management framework that enables the use of sTILs as a stratification factor in clinical trials. We present the design of a biomarker risk-mitigation workflow that can be applied to any biomarker incorporation in clinical trials. We demonstrate the implementation of this concept using sTILs as an integral biomarker in a single-center phase II immunotherapy trial for metastatic TNBC (TONIC trial, NCT02499367), using this workflow to mitigate risks of suboptimal inclusion of sTILs in this specific trial. In this review, we demonstrate that a web-based scoring platform can mitigate potential risk factors when including sTILs in clinical trials, and we argue that this framework can be applied for any future biomarker-driven clinical trial setting

Driver Fusions and Their Implications in the Development and Treatment of Human Cancers.

Gene fusions represent an important class of somatic alterations in cancer. We systematically investigated fusions in 9,624 tumors across 33 cancer types using multiple fusion calling tools. We identified a total of 25,664 fusions, with a 63% validation rate. Integration of gene expression, copy number, and fusion annotation data revealed that fusions involving oncogenes tend to exhibit increased expression, whereas fusions involving tumor suppressors have the opposite effect. For fusions involving kinases, we found 1,275 with an intact kinase domain, the proportion of which varied significantly across cancer types. Our study suggests that fusions drive the development of 16.5% of cancer cases and function as the sole driver in more than 1% of them. Finally, we identified druggable fusions involving genes such as TMPRSS2, RET, FGFR3, ALK, and ESR1 in 6.0% of cases, and we predicted immunogenic peptides, suggesting that fusions may provide leads for targeted drug and immune therapy

Erratum: "A Gravitational-wave Measurement of the Hubble Constant Following the Second Observing Run of Advanced LIGO and Virgo" (2021, ApJ, 909, 218)

[no abstract available